Literature DB >> 10501658

Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen.

K Joseph1, Y Nakazawa, W F Bahou, B Ghebrehiwet, A P Kaplan.   

Abstract

Domains 3 and 5 of high-molecular-weight kininogen (HK) have been shown to bind to platelets in a zinc-dependent reaction. However, the platelet-binding proteins responsible for this interaction have not been identified. We have focused on the platelet-binding site for the heavy chain (domain 3), which we approached using a domain 3-derived peptide ligand and isolated binding proteins by affinity chromatography. The domain 3-derived peptide, thrombin, HK, factor XII, as well as antibody to glycocalicin (the N-terminal portion of the alpha chain of GPIb) recognized a protein at 74 kD. We also isolated the thrombin receptor (PAR 1) at 45 kD, however, none of the above-mentioned ligands bound to this protein. Isolation of platelet membrane proteins using a monoclonal anti-glycocalicin antibody column revealed the same HK binding protein at 74 kD, which was reactive with anti-GPIb and represents a GPIb fragment. By photoaffinity labeling, HK interacted with membrane GPIb, which was then isolated in native form (135 kD) along with gC1qR, a ligand for the HK light chain. Finally, (125)I-HK binding to platelets was significantly inhibited by the anti-GPIb antibody. These results suggest that the GPIb alpha chain, a known thrombin binding protein, is also one of the zinc-dependent platelet membrane binding sites for HK domain 3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501658      PMCID: PMC2230456     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  21 in total

1.  Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.

Authors:  Y P Jiang; W Muller-Esterl; A H Schmaier
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.

Authors:  R N Puri; F Zhou; C J Hu; R F Colman; R W Colman
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

5.  Evidence that glycocalicin circulates in normal plasma.

Authors:  B S Coller; E Kalomiris; M Steinberg; L E Scudder
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

6.  Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders.

Authors:  M H Steinberg; J G Kelton; B S Coller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

7.  High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.

Authors:  F J Meloni; E J Gustafson; A H Schmaier
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

8.  Receptors for high molecular weight kininogen on stimulated washed human platelets.

Authors:  J S Greengard; J H Griffin
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

View more
  7 in total

Review 1.  14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

Authors:  Yunfeng Chen; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

Review 2.  Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib.

Authors:  Zaverio M Ruggeri; Alessandro Zarpellon; James R Roberts; Richard A Mc Clintock; Hua Jing; G Loredana Mendolicchio
Journal:  Thromb Haemost       Date:  2010-10-12       Impact factor: 5.249

Review 3.  The organizing principle of the platelet glycoprotein Ib-IX-V complex.

Authors:  R Li; J Emsley
Journal:  J Thromb Haemost       Date:  2013-04       Impact factor: 5.824

4.  Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.

Authors:  Narayanan Parthasarathy; Suzy V Torti; Frank M Torti
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

5.  Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin.

Authors:  O Kassaar; U Schwarz-Linek; C A Blindauer; A J Stewart
Journal:  J Thromb Haemost       Date:  2014-11-22       Impact factor: 5.824

Review 6.  The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis.

Authors:  Gerd Bendas; Martin Schlesinger
Journal:  Exp Hematol Oncol       Date:  2022-04-02

Review 7.  Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.

Authors:  Monika Pathak; Bubacarr Gibril Kaira; Alexandre Slater; Jonas Emsley
Journal:  Front Med (Lausanne)       Date:  2018-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.